Intellia Therapeutics Inc (NTLA)

Other Income/Expenses (Net)

$23.50M

TTM · Period ending: · USD

NTLA logo

NTLA Other Income/Expenses (Net)

Latest reported$23.50M
NTLA TTM Other Income/Expenses (Net) ($0.00 → $23.50M)
High-resolution chart · PNG

NTLA other income/expenses (net) history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Intellia Therapeutics Inc Other Income/Expenses (Net) — Trailing twelve months (TTM) (USD)
Period endingOther Income/Expenses (Net) (USD)
23,504,000
26,119,000
28,296,000
32,921,000
31,826,000
15,153,000
15,242,000
15,424,000
15,249,000
31,834,000
34,099,000
23,048,000
6,466,000
-4,564,000
-16,022,000
-13,524,000
-5,476,000
-2,888,000
-42,000
987,000
900,000
1,330,000
2,352,000
3,640,000
5,072,000
6,208,000
6,835,000
7,020,000
6,723,000
6,322,000
5,527,000
4,599,000
3,721,000
2,769,000
2,012,000
1,519,000
1,215,000
837,000
525,000
266,000
51,000
5,000
0
-3,027,500
-3,016,500
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.